Literature DB >> 15122205

The TOR pathway: a target for cancer therapy.

Mary-Ann Bjornsti1, Peter J Houghton.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15122205     DOI： 10.1038/nrc1362

Source DB:  PubMed          Journal:  Nat Rev Cancer        ISSN： 1474-175X            Impact factor:   60.716


× No keyword cloud information.
  439 in total

1.  Decreased level of PDCD4 (programmed cell death 4) protein activated cell proliferation in the lung of A/J mouse.

Authors:  Soon-Kyung Hwang; Arash Minai-Tehrani; Hwang-Tae Lim; Ji-Young Shin; Gil-Hwan An; Kee-Ho Lee; Kee-Rang Park; Yeon-Soo Kim; George R Beck; Hsin-Sheng Yang; Myung-Haing Cho
Journal:  J Aerosol Med Pulm Drug Deliv       Date:  2010-10       Impact factor: 2.849

2.  Efficacy of RAD001 (everolimus) against advanced gastric cancer with peritoneal dissemination.

Authors:  Fumiko Taguchi; Yasuo Kodera; Yasufumi Katanasaka; Kazuyoshi Yanagihara; Tomohide Tamura; Fumiaki Koizumi
Journal:  Invest New Drugs       Date:  2010-06-08       Impact factor: 3.850

3.  CaMKII is involved in cadmium activation of MAPK and mTOR pathways leading to neuronal cell death.

Authors:  Sujuan Chen; Yijiao Xu; Baoshan Xu; Min Guo; Zhen Zhang; Lei Liu; Hongwei Ma; Zi Chen; Yan Luo; Shile Huang; Long Chen
Journal:  J Neurochem       Date:  2011-10-20       Impact factor: 5.372

Review 4.  A review of the association between osteosarcoma metastasis and protein translation.

Authors:  T S Osborne; C Khanna
Journal:  J Comp Pathol       Date:  2012-01-31       Impact factor: 1.311

Review 5.  The potential role of mTOR inhibitors in the treatment of endocrine tumors.

Authors:  S Grozinsky-Glasberg; I Shimon
Journal:  J Endocrinol Invest       Date:  2010-05-05       Impact factor: 4.256

6.  Targeting the VEGF and PDGF signaling pathway in glioblastoma treatment.

Authors:  Alisa Madalina Popescu; Oana Alexandru; Corina Brindusa; Stefana Oana Purcaru; Daniela Elise Tache; Ligia Gabriela Tataranu; Citto Taisescu; Anica Dricu
Journal:  Int J Clin Exp Pathol       Date:  2015-07-01

Review 7.  Pharmacotherapeutic management of pediatric gliomas : current and upcoming strategies.

Authors:  Trent R Hummel; Lionel M Chow; Maryam Fouladi; David Franz
Journal:  Paediatr Drugs       Date:  2013-02       Impact factor: 3.022

8.  Ser2481-autophosphorylated mTOR colocalizes with chromosomal passenger proteins during mammalian cell cytokinesis.

Authors:  Alejandro Vazquez-Martin; Tamara Sauri-Nadal; Octavio J Menendez; Cristina Oliveras-Ferraros; Sílvia Cufí; Bruna Corominas-Faja; Eugeni López-Bonet; Javier A Menendez
Journal:  Cell Cycle       Date:  2012-10-24       Impact factor: 4.534

Review 9.  Advances in myelofibrosis: a clinical case approach.

Authors:  John O Mascarenhas; Attilio Orazi; Kapil N Bhalla; Richard E Champlin; Claire Harrison; Ronald Hoffman
Journal:  Haematologica       Date:  2013-10       Impact factor: 9.941

10.  Overexpression of phospho-eIF4E is associated with survival through AKT pathway in non-small cell lung cancer.

Authors:  Akihiko Yoshizawa; Junya Fukuoka; Shigeki Shimizu; Konstantin Shilo; Teri J Franks; Stephen M Hewitt; Takeshi Fujii; Carlos Cordon-Cardo; Jin Jen; William D Travis
Journal:  Clin Cancer Res       Date:  2009-12-15       Impact factor: 12.531
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.